A Bold Step into the Future of Cardiac Care: The Birth of SonicPrecision
18 October 2024 marks the official founding of SonicPrecision, a moment that illustrated our commitment to transforming cardiac arrhythmia treatment. After completing the HealthTech venture builder program the month before, we took the leap into the “real world”—turning our vision into reality in our own company.
At the heart of SonicPrecision lies a shared passion: improving people’s lives through medical technology. We were given a unique opportunity to license ultrasound vision technology from Philips—a breakthrough that could address a critical gap in electrophysiology. With this, we set out to build something differentiating: a catheter that gives electrophysiologists real-time feedback on lesion durability during ablation procedures. Today, they work in the dark, unsure if they are over-treating or under-treating. Our mission is to bring clarity, precision, and confidence to this life-saving procedure.
A Journey Fueled by Innovation & Community
The venture builder program was a whirlwind—intense, challenging, and eye-opening. More than anything, it showed us the power of the Brainport ecosystem, where cutting-edge technology meets world-class clinical and technical expertise. We learned what it takes to become investor-ready, how to refine our business case, and most importantly, that big dreams need strong networks.
SonicPrecision started with founders brave enough to embark on this adventure. But we are far from alone. Our growing support system, including mentors, industry experts, and fellow entrepreneurs, fuels our journey. The excitement of establishing our company is hard to describe—this is the real deal. We’ve committed ourselves to years of intense innovation, pushing boundaries, and making a real impact up to the level of patients. The stakes are high, but so is the sense of purpose. It’s all up to us now.
What’s Next? The Road Ahead
Starting a med-tech company is a marathon, not a sprint. Our immediate focus is on raising funds, building our team, forming key partnerships, developing our first prototype, and generating clinical evidence. Each step brings us closer to our ultimate goal: setting a new standard in cardiac ablation treatment, where optimal patient health outcomes drive every decision.
And while the work is serious, we intend to learn tons and have loads of fun along the way. After all, bringing breakthrough innovation to life is as much about the journey as it is about the destination.
